{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:48:33Z","timestamp":1753876113800,"version":"3.41.2"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The administration of propofol and methylene blue (MB) can be associated with the appearance of prolonged green urine discoloration, particularly in patients with heart failure (HF) concomitant with renal and liver dysfunction. Understanding the reasons behind this phenomenon is of clinical significance.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>A 79-year-old woman with a history of HF experienced dyspnoea and persistent green urine discoloration for a week, leading to her hospitalization for acutely decompensated HF. A recent dual-chamber rate-modulated-pacemaker implantation had necessitated propofol sedation and the administration of 100\u2005mg of MB due to methaemoglobinaemia. Upon admission, the patient exhibited elevated levels of brain natriuretic peptide (BNP) and liver function tests, as well as a significant decrease in glomerular filtration rate (GFR). Initial therapy with intravenous furosemide yielded an inadequate response, requiring the initiation of combined diuretic therapy (CDT). The patient's condition improved with CDT, resulting in the normalization of BNP, liver function tests, and GFR, along with the restoration of normal urine colour lasting 12 days.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>Our case report sheds light on the complex interaction between drug metabolic pathways and their potential for prolonged side effects, particularly in patients with multiorgan dysfunction. The association between propofol, MB, and green urine discoloration in the context of HF warrants further investigation, emphasizing the need for increased awareness of drug interactions and their implications in complex clinical scenarios.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytad570","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:44:16Z","timestamp":1700009056000},"source":"Crossref","is-referenced-by-count":0,"title":["An interesting observation: prolonged green urine can be a combined effect of decreased liver and renal function in a patient with heart failure\u2014a case report"],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2227-6177","authenticated-orcid":false,"given":"Tu\u011f\u00e7e","family":"\u00c7\u00f6ll\u00fco\u011flu","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Department of Cardiology, Karab\u00fck University , Karab\u00fck , T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melahat Hicran","family":"Aksu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Cardiology, Karab\u00fck University , Karab\u00fck , T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orhan","family":"\u00d6nalan","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Cardiology, Karab\u00fck University , Karab\u00fck , T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye\u015fim","family":"Ak\u0131n","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Department of Cardiology, Karab\u00fck University , Karab\u00fck , T\u00fcrkiye"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"2024030520011184900_ytad570-B1","first-page":"242514","article-title":"Green urine discoloration due to propofol infusion: a case report","volume":"2011","author":"Shioya","year":"2011","journal-title":"Case Rep Emerg Med"},{"key":"2024030520011184900_ytad570-B2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ccr3.891","article-title":"Green urine","volume":"5","author":"Koratala","year":"2017","journal-title":"Clin Case Rep"},{"key":"2024030520011184900_ytad570-B3","first-page":"213","article-title":"Green urine\u2014understanding its importance","volume":"42","author":"Barros Pinto","year":"2018","journal-title":"J Lab Med"},{"key":"2024030520011184900_ytad570-B4","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00003495-199550030-00008","article-title":"Propofol: an update of its use in anaesthesia and conscious sedation","volume":"50","author":"Bryson","year":"1995","journal-title":"Drugs"},{"key":"2024030520011184900_ytad570-B5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/0970-9185.202190","article-title":"Green urine: a cause for concern?","volume":"33","author":"Prakash","year":"2017","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"2024030520011184900_ytad570-B6","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1592\/phco.20.13.1120.35041","article-title":"Clinical significance of rare and benign side effects: propofol and green urine","volume":"20","author":"Blakey","year":"2000","journal-title":"Pharmacotherapy"},{"key":"2024030520011184900_ytad570-B7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/ALN.0b013e31823a13bc","article-title":"Propofol induction resulting in green urine discoloration","volume":"116","author":"Barbara","year":"2012","journal-title":"Anesthesiology"},{"key":"2024030520011184900_ytad570-B8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4097\/kjae.2013.65.2.177","article-title":"Green discoloration of urine after propofol infusion","volume":"65","author":"Lee","year":"2013","journal-title":"Korean J Anesthesiol"},{"key":"2024030520011184900_ytad570-B9","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1007\/s40262-018-0672-3","article-title":"Clinical pharmacokinetics and pharmacodynamics of propofol","volume":"57","author":"Sahinovic","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"2024030520011184900_ytad570-B10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2125.2005.02393.x","article-title":"Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain","volume":"60","author":"Hiraoka","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"2024030520011184900_ytad570-B11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0140-6736(87)91097-X","article-title":"Propofol infusion and green urine","volume":"330","author":"Bodenham","year":"1987","journal-title":"Lancet (London, Engl)"},{"key":"2024030520011184900_ytad570-B12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s002280000124","article-title":"Pharmacokinetics and organ distribution of intravenous and oral methylene blue","volume":"56","author":"Peter","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"2024030520011184900_ytad570-B13","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/j.athoracsur.2004.10.038","article-title":"Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery","volume":"79","author":"Ozal","year":"2005","journal-title":"Ann Thorac Surg"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytad570\/53477394\/ytad570.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/7\/12\/ytad570\/56845545\/ytad570.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/7\/12\/ytad570\/56845545\/ytad570.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,5]],"date-time":"2024-03-05T20:01:27Z","timestamp":1709668887000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytad570\/7424863"}},"subtitle":[],"editor":[{"given":"Vincenzo","family":"Nuzzi","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Waqas","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Subhi","family":"Akleh","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Pok-Tin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytad570","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,11,16]]},"article-number":"ytad570"}}